Navigation Links
Rheumatoid Arthritis Treatment Guidelines Updated
Date:6/26/2008

of disease activity.
  • Prescribing anti-TNF agents -- etanercept, infliximab, or adalimumab -- along with methotrexate in early RA (less than 3 months) only for patients with high disease activity who had never received DMARDs. In intermediate- and longer-duration RA, anti-TNF agents are recommended for patients who had failed to respond adequately to methotrexate therapy.
  • Reserving the fusion protein abatacept and the B-cell antibody rituximab for patients with at least moderate disease activity and poor disease prognosis for whom methotrexate in combination with or sequential administration of other nonbiologic DMARDs led to an inadequate response.
  • Avoiding the initiation or resumption of treatment with methotrexate, leflunomide, or biologic agents for patients with active bacterial infection, active herpes-zoster viral infection, active or latent tuberculosis, or acute or chronic hepatitis B or C.
  • Not prescribing anti-TNF agents to patients with a history of heart failure, with a history of lymphoma, or with multiple sclerosis or demyelinating disorders.
  • Avoiding the initiation or resumption of methotrexate, leflunomide, or minocycline for RA patients planning for pregnancy and throughout the duration of pregnancy and breastfeeding.

    • "These recommendations are extensive but not comprehensive, and it is intended that they will be regularly updated to reflect the rapidly growing scientific evidence in this area along with changing practice patterns in rheumatology," Saag said.

    More information

    The Arthritis Foundation has more about arthritis treatments.



    -- Robert Preidt



    SOURCE: American College of Rheumatology, news release, June 3, 2008


    '/>"/>
    Copyright©2008 ScoutNews,LLC.
    All rights reserved

    3

    GOOD

    Page: 1 2 3

    Related medicine news :

    1. Rheumatoid Arthritis Drug Boosts Melanoma Incidence
    2. Rheumatoid arthritis is a risk factor for cardiovascular disease
    3. Novel DNA microarray chip predicts functional impairment and remission in rheumatoid arthritis
    4. Early life infections increase the risk of rheumatoid arthritis and juvenile idiopathic arthritis
    5. Rheumatoid arthritis factors equal to cardiovascular factors in risk of severe cardiovascular events
    6. New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
    7. HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity
    8. Hand bone mineral density is an effective predictor of mortality in rheumatoid arthritis
    9. Biogen Idecs baminercept alfa shows promise in patients with rheumatoid arthritis
    10. Golimumab Eases Rheumatoid Arthritis Symptoms
    11. Researchers uncover higher prevalence of periodontal disease in rheumatoid arthritis patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/10/2008)...ng point for behavior change, DES MOINES, Iowa, O...,Americans (51 percent) believe there are good thi...r changes are needed, according to the 2008,EBRI H...oday by the,Employee Benefit Research Institute an...derwritten by the Principal Financial Group(R)., ...
    (Date:10/10/2008)...dentialing Center (ANCC) has designated Geisinger ...s came via a conference call to hospital administr...and applause., GMC joins an elite group of only 1...n the United States that have achieved Magnet stat...s recognition., "Achieving Magnet designation is ...
    (Date:10/10/2008)... blame , , FRIDAY, Oct. 10 (HealthDay Ne...ve diabetes, being depressed was associated with a..., Publishing in the October issue of the Journal...he University of Washington tracked 10,704 Medicar...d diabetes and were enrolled in a disease manageme...
    (Date:10/10/2008)...llence in the implementation of electronic health ...agement Systems Society (HIMSS) announces the reci...onal, Ambulatory and Community Health Organization...L (PRWEB) October 10, 2008 -- Honoring excellence ... (EHRs), the Healthcare Information and Managemen...
    Breaking Medicine News(10 mins):Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 2Health News:Video: Just What the Doctor Ordered: Survey Shows Americans Adopting Healthier Lifestyles 3Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5
    ...employed to remove abnormal cells in the cervix co..., reveals a new study conducted by researchers at ... good for laser ablation, highlights the study pub...further added that women who need such treatments ...
    ...nveiled a scheme to eradicate malnutrition among c...and Family Welfare Ajay Vishnoi said. The 'Bal Sh...emented jointly by the public health and the women...rtments, Vishnoi told reporters here. "The scheme...
    ...hs — a group fascinated by the darker side of huma...icide attempts//. University of Glasgow in Scot...ults several times throughout their teen years. In...aid they were goths admitted to self-harm, and 47 ...
    ... contact lens solution from the US market on Thurs...close the facts of the // solution, which is impli.... Wal-Mart Stores Inc., Walgreen Co. and other re...olution from their shelves and they were joined on...
    Other Medicine News:Health News:Cervical Procedures Increase Risk Of Pregnancy Complications 2
    (Date:10/9/2008)...ocuses on the need to protect the eyesight of,olde... 45 million people worldwide who,are blind, 80 per...ould,have avoided their blindness if they had been...imedia News Release, go to:, http://www.prnewswire... in eye care products and equipment, is,partnering...
    (Date:10/9/2008)...- Diamyd Medical reports,th...he New England Journal,of Medicine, has published ...f the Diamyd(R) diabetes vaccine for type 1 diabet...20080314/297194 ), The article is now available ...and will be in print on October 30. It presents th...
    (Date:10/8/2008)...e Pioneers Research That May Offer New Hope to,Hea... -- Nationally, over 3,000 people are,waiting for ...y, only half,of those will receive a transplant. N... (AHI) is paving the way for how to treat congesti...timedia News Release, go to:, http://www.prnewswir...
    (Date:10/8/2008)... Potency of Poly-ICR as Vaccine Adjuvant, SAN DIE...rmaceuticals,Corporation (TSX: NVN) today presente... proprietary Toll-like Receptor 3 agonist, Poly IC...ngress 2008 in Lyon, France.,Study results demonst...geting the Toll-like Receptor 3 (TLR3) pathway. Da...
    Breaking Medicine Technology:ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 382 1Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 382 2Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation 382 3Survival data presented from phase II study of hormone resistant prostate cancer patients 1991 1Survival data presented from phase II study of hormone resistant prostate cancer patients 1991 2Genes and environment grant funds close look at nature nurture overlap in common diseases 558 1Genes and environment grant funds close look at nature nurture overlap in common diseases 558 2Genes and environment grant funds close look at nature nurture overlap in common diseases 558 3New use for stem cells found in war on terrorism 556 1New use for stem cells found in war on terrorism 556 2New use for stem cells found in war on terrorism 556 3
    0.5 mm, 1 x 2 teeth set at 45 degrees and 6 mm tying platform. Serrated handle with polished finish.
    5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 90 degrees.
    Colibri style tips with 0.12 mm, 1 x 2 teeth. Round knurled handle with alignment pin and polished finish.
    0.12 mm, 1 x 2 teeth set at 45 degrees with 6 mm tying platform. Wide serrated handle with polished finish.
    Medicine Products: